ArticleNature cancer2022
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors.
Bram Herpers et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
95 papers cite itlatest 60 shown
this paperpooled itcites it